<HTML>
<HEAD>
<TITLE>7.8.3 CSU - message reporting monthly patient data updates to th</TITLE>
<LINK REL="ToC" HREF="httoc.htm">
<LINK REL="Index" HREF="htindex.htm">
<LINK REL="Next" HREF="ch700038.htm">
<LINK REL="Previous" HREF="ch700036.htm"></HEAD>
<BODY BACKGROUND="images/grenszig.gif">
<P ALIGN=LEFT>
<A HREF="ch700036.htm" TARGET="_self"><IMG SRC="images/blrprev.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Previous Page"></A>
<A HREF="httoc.htm" TARGET="_self"><IMG SRC="images/blrtoc.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="TOC"></A>
<A HREF="htindex.htm" TARGET="_self"><IMG SRC="images/blrindex.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Index"></A>
<A HREF="ch700038.htm" TARGET="_self"><IMG SRC="images/blrnext.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Next Page"></A>
<P>

<A NAME="E12E311"></A>
<H3><B>7.8.3</B><B> </B><A NAME="I2"></A><B>CSU - message reporting monthly patient data updates to the sponsor</B></H3>
<PRE>
<FONT FACE="Courier New" SIZE=3>MSH|^~\&amp;|PDMS|MDACC|CTMS|NCI|||CSU^C09 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>CMO|1|T93-0800^^NCI|ID93-030^Ph I Study of Oral Fostriecin^MDACC|
<BR>     |235^Alexander^Susan^B.^^^MD^MDACC|19940801|14|19941205|^Sam Smith &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>CM2|1|^Prestudy^NCI|Prestudy Eligibility and Baseline Clinical Params|
<BR>     ^CBC~^SMA12~^Pathology~^Elig.checklist~^Prestudy Form~^
<BR>     Imaging procedures as indicated &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>CM2|2|^Course Completion^NCI|Course Completion Toxicity and Response .....Evaluation|Adverse Events Form~^Course Completion Form~^CEA &lt;cr&gt;</FONT></PRE>

<TABLE >
<TR>
<TD WIDTH=493 VALIGN=top >
<PRE>
<FONT FACE="Courier New" SIZE=3>PID|1|235925||J^F^M||19350616 &lt;cr&gt;</FONT></PRE>
</TD><TD WIDTH=145 VALIGN=top >
<P>[note: anonymous]</TD></TR></TABLE><PRE>
<FONT FACE="Courier New" SIZE=3>CSR||T93-080^^NCI|ID93-030^^MDACC|MDACC|14||19941205 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>CSS||^Prestudy|19941204|C^compliant^NCI &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|1|||3^EligibilChecklist^StudyFormsList|||19941205 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|CE|ELIG1^Elig Crit 1^NCI|Text Elig Crit 1|Y &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|CE|ELIG2^Elig Crit 2^NCI||Y &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|2|||4^Prestudy Form^StudyFormsList|||19941205 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|CE|QOL^Quality of Life^NCI||2&amp;3&amp;2&amp;4&amp;2^SPITZER &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|CE|PRICHEM^Prior Chemo^NCI||Yes &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|3|CE|PRIBIOL^Prior Biologics^NCI||No &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|4|NM|NUMREM^Number Prior Remissions^NCI||2 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|3|||88304^SURG PATH REPORT|||19940101 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|CE|88304&amp;ANT|1|9999^PANCREAS^SNM &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|CE|88304&amp;IMP|2|9999^ADENOCARCINOMA^SNM &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|4|||85022^CBC|||199412050800 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|ST|718-7^HEMOGLOBIN:^LN||13.4|GM/DL|14-18|N||S|F|19860522&lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>[cbc values]</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|ST|4544-3^HEMATOCRIT:^LN||40.3|%|42-52|L||S|F|19860522 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|3|ST|789-8^ERYTHROCYTES:^LN||4.56|10*6/ml|4.7-6.1|L||S|F|19860522 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|4|ST|787-22^ERYTHROCYTE MEAN CORPUSCULAR VOLUME:^LN||88|fl</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>   |80-94|N||S|F|19860522 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|5|ST|785-6^ERYTHROCYTE MEAN CORPUSCULAR HEMOGLOBIN:^LN||29.5|pg</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>   |27-31|N||N|F|19860522 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|6|ST|786-4^ERYTHROCYTE MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION:^LN| </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>   |33|%|33-37|N||N|F|19860522 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|7|ST|6690-2^LEUKOCYTES:^LN||10.7|10*3/ml|4.8-10.8|N||N|F|19860522 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|8|ST|764-1^NEUTROPHILS BAND FORM/100 LEUKOCYTES:^LN||2|%||||F &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|9|ST|769-0^NEUTROPHILS SEGMENTED/100 LEUKOCYTES:^LN||67|%||||F &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|10|ST|736-9^LYMPHOCYTES/100 LEUKOCYTES:^LN||29|%||||F &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|11|ST|5905-5^MONOCYTES/100 LEUKOCYTES:^LN||1|%||||F &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|12|ST|713-8^EOSINOPHILS/100 LEUKOCYTES:^LN||2|%||||F &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|5|||80004^ELECTROLYTES|||199412050800 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|ST|2947-0^SODIUM:^LN||150|mmol/l|136-148|H||A|F|19850301 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|ST|2823-3^POTASSIUM:^LN||4.5|mmol/l|3.5-5|N||N|F|19850301 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>[electrolytes values]</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|3|ST|2069-3^CHLORIDE:^LN||102|mmol/l|94-105|N||N|F|19850301 &lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|4|ST|2028-9^CARBON DIOXIDE.TOTAL:^LN||27|mmol/l|24-31|N||N|F </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>   |19850301&lt;cr&gt; </FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>CSP|1|^Course 1|19941205|19950120|Y^Toxicity and Response^NCI &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>CSS|1|^Course Completion|19950120| &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|1|||2039-6^CARCINOEMBRYONIC AG:^LN|||19941008 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>   OBX|1|NM|2039-6^CARCINOEMBRYONIC AG:^LN||15.2|IU &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|2|||10^Course Completion Form^StudyPhaseFormsList|||19950120 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|CE|CRSRESP^Course Response^NCI||4^Partial Response &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|NM|DRUGDISP^Capsules Dispensed^NCI||60 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|3|NM|DRUGRETN^Capsules Returned^NCI||5 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|4|ID|DXCOMP^Diagnostic Tests Compliance^NCI||Y &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|5|CE|PERSTAT^Performance Status^NCI||3^ZUBRODS &lt;cr&gt;</FONT></PRE>

<TABLE >
<TR>
<TD WIDTH=475 VALIGN=top >
<PRE>
<FONT FACE="Courier New" SIZE=3>OBR|3|||9999^Adverse Events &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|1|CE|9999&amp;EVENT|1|45^Vomiting^NCI &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|2|DT|9999&amp;ONSET|1|19941215 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|3|DT|9999&amp;RESOLUTION|1|19941217 &lt;cr&gt;</FONT></PRE>
</TD><TD WIDTH=163 VALIGN=top >
<P>[Note: Needs to maintain compatibility with ongoing product experience message efforts.]</TD>
</TR>
<TR>
<TD WIDTH=475 VALIGN=top >
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|4|ID|9999&amp;GRADE|1|M^MODERATE &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|5|ID|9999&amp;RELATION_TO_RX|1|L^LIKELY &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|6|CE|9999&amp;EVENT|2|303^Dyspnea^NCI &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|7|DT|9999&amp;ONSET|2|19941231 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|8|DT|9999&amp;RESOLUTION|2 &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|9|ID|9999&amp;GRADE|2|MI^MILD &lt;cr&gt;</FONT></PRE>
<PRE>
<FONT FACE="Courier New" SIZE=3>OBX|10|ID|9999&amp;RELATION_TO_RX|2|U^UNLIKELY &lt;cr&gt;</FONT></PRE>
</TD><TD WIDTH=163 VALIGN=top >
<P>[Note2: There are other possible OBX suffixes defined by FDA: APEX/ NADIR, ACTION, THERAPY, OUTCOME, RECHALLENGE.]</TD></TR></TABLE><P>
<P ALIGN=LEFT>
<A HREF="ch700036.htm" TARGET="_self"><IMG SRC="images/blrprev.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Previous Page"></A>
<A HREF="httoc.htm" TARGET="_self"><IMG SRC="images/blrtoc.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="TOC"></A>
<A HREF="htindex.htm" TARGET="_self"><IMG SRC="images/blrindex.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Index"></A>
<A HREF="ch700038.htm" TARGET="_self"><IMG SRC="images/blrnext.gif" WIDTH = 32 HEIGHT = 32 BORDER = 0 ALT="Next Page"></A>
</BODY></HTML>
